Form 4: Phreesia Director Exercises Options and Sells Shares Under Pre-Arranged Plan
Insider Transaction Report
Phreesia, Inc. Director Mark Douglas Smith exercised stock options and subsequently sold an equivalent number of common shares on July 2, 2025, as part of a pre-arranged trading plan.
Summary
- Director Mark Douglas Smith of Phreesia, Inc. engaged in transactions involving the company's common stock.
- On July 2, 2025, Smith exercised stock options to acquire 7,000 shares of common stock at an exercise price of $4.71 per share.
- Immediately following the option exercise, Smith sold 7,000 shares of common stock at a price of $29.00 per share.
- These transactions were conducted under a Rule 10b5-1 trading plan established on January 10, 2025.
- Following these transactions, Smith directly beneficially owns 37,353 shares of common stock and 51,193 stock options.
Sentiment
Score: 6
Explanation: The filing reports a routine insider transaction where a director exercised options and sold shares for a profit, executed under a pre-arranged trading plan, which is generally viewed neutrally or slightly positively due to transparency.
Positives
- Director Mark Douglas Smith realized a significant profit by selling shares at $29.00 after exercising options at $4.71.
- The transactions were executed under a Rule 10b5-1 trading plan, indicating a pre-scheduled and transparent sale not based on inside information.
Negatives
- Director Mark Douglas Smith sold 7,000 shares of common stock, which could be interpreted by some investors as a reduction in direct ownership stake, although it was part of an option exercise and sale.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- Director Mark Douglas Smith exercised stock options and sold common stock of Phreesia, Inc., which constitutes an insider transaction.
Stakeholder Impact
- Shareholders may view the sale as a director reducing exposure, but the execution under a Rule 10b5-1 plan mitigates negative interpretations.
- The profit realized by the director from the option exercise and sale could be seen as a positive sign of value creation for long-term shareholders.
Key Dates
| Date | Description |
|---|---|
| 01/10/2025 | Rule 10b5-1 trading plan adopted by the Reporting Person. |
| 07/02/2025 | Date of earliest transaction, including stock option exercise and common stock sale. |
| 07/03/2025 | Signature date of the Form 4 filing. |
| 09/04/2028 | Expiration date of the exercised stock option. |
Keywords
Phreesia, PHR, Form 4, Insider Transaction, Stock Options, Director, Share Sale, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.